Targeted inhibition of Vps34 using siRNA-mediated knockdown or pharmacological inhibition blocked the induction of autophagy in response to HER2/PI3K inhibitors, thus increasing therapeutic tumor cell killing in HER2-amplified breast cancer cells. Here, PIK3CA is linked to neoplasm.